0001567619-21-008381.txt : 20210420
0001567619-21-008381.hdr.sgml : 20210420
20210420215318
ACCESSION NUMBER: 0001567619-21-008381
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210419
FILED AS OF DATE: 20210420
DATE AS OF CHANGE: 20210420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis George Eric
CENTRAL INDEX KEY: 0001380710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 21839455
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2021-04-19
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001380710
Davis George Eric
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
EVP, General Counsel
Common Stock
2021-04-19
4
M
0
2709
26.49
A
71149
D
Common Stock
2021-04-19
4
S
0
2709
79.58
D
68440
D
Stock Option (Right to buy Common Stock)
26.49
2021-04-19
4
M
0
2709
0
D
2011-11-12
2021-05-11
Common Stock
2709
0
D
Trade made pursuant to a 10b5-1 plan executed on March 12, 2021.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2021-04-20